Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
Official title: Pilot Development of a Youth-Focused Digital Just-in-Time Adaptive Intervention to Enhance Reward Sensitivity and Reduce Suicidal Ideation
Run by University of Pennsylvania · NCT07661901 · Data updated 2026-11-12
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 17 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | August 21, 2026 |
| Main results expected | June 2027 |
| Study ends | September 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07661901 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents aged 13-17 with recent suicidal ideation, owning a smartphone, and living in the Philadelphia metropolitan area, plus their English-speaking legal guardians.
✕Probably not a fit
Teens with high imminent suicide risk or certain psychiatric conditions may not benefit from the digital approach as implemented.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a just-in-time, adaptive digital intervention designed to boost reward sensitivity and positive emotions in adolescents at risk of suicide. The app provides brief, real-time coping activities and mood prompts throughout the day, paired with ecological momentary assessments to track mood, motivation, and context. Phase 1 focuses on co-design with teens and their guardians to ensure usability and acceptability, with ongoing surveys and interviews to evaluate user experience and mood outcomes. Participants are adolescents aged 13-17 with recent suicidal ideation and residing in the Philadelphia area, along with their English-speaking legal guardians. The trial is conducted at the University of Pennsylvania under an interventional framework aimed at suicide prevention through digital health tools.
Why it matters
Potential benefit: If successful, the app could offer a practical way to reduce suicidal thoughts and improve emotional well-being in adolescents who struggle with anhedonia.
How similar studies have gone: Previous digital interventions show promise for mood and suicidality reduction, but this co-design, just-in-time approach is relatively novel in this exact population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: ADOLESCENTS * Aged 13-17 years old * Recent suicidal ideation * Access to a smartphone device * Residing in the Philadelphia metropolitan area LEGALGUARDIANS * They are the legal guardian of an adolescent that meets all study criteria (see above) * They can read, write, and speak English Exclusion Criteria: ADOLESCENTS * Psychotic disorder, including schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified, with a past year psychotic episode prior to baseline * Bipolar disorder I diagnosis, with a past year manic episode prior to baseline * Imminent suicide risk (e.g., active suicidal ideation with a specific plan and intent) LEGALGUARDIANS \- There are no exclusion criteria for legal guardians
Where it's running
-
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Marin Kautz, Ph.D. — University of Pennsylvania
- Study coordinator: Sydney Lempert, B.A.
- Email: Sydney.Lempert@Pennmedicine.upenn.edu
- Phone: 215-746-3337
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving coping to reduce suicide risk after ED discharge
This study tests whether an electronic safety plan and supportive text messages can help adults who have recently had suicidal thoughts or behaviors after leaving the emergency department.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.